173 related articles for article (PubMed ID: 1804599)
1. Randomized clinical trial comparing ceftriaxone/amikacin versus ceftazidime/amikacin as initial therapy of febrile episodes in neutropenic patients.
Yataganas X; Rombos Y; Vayopoulos G; Meletis J; Avlami A
Chemotherapy; 1991; 37(5):376-81. PubMed ID: 1804599
[TBL] [Abstract][Full Text] [Related]
2. Ceftriaxone and amikacin versus ceftazidime and amikacin in febrile granulocytopenia.
Schmid L; Jeschko M; Wilder-Smith C; Schafroth U; Thürlimann B; Pedrazzini A; Senn H
Chemotherapy; 1991; 37(5):346-52. PubMed ID: 1804595
[TBL] [Abstract][Full Text] [Related]
3. A prospective, controlled, randomized, non-blind, comparative study of the efficacy and safety of a once daily high dose of ceftriaxone plus ciprofloxacin versus thrice daily ceftazidime plus amikacin in empirical therapy for febrile neutropenic patients.
Metallidis S; Kollaras P; Giannakakis T; Seitanidis B; Kordosis T; Nikolaidis J; Hatzitolios A; Nikolaidis P
Eur J Intern Med; 2008 Dec; 19(8):619-24. PubMed ID: 19046729
[TBL] [Abstract][Full Text] [Related]
4. Ceftriaxone plus conventional or single-daily dose amikacin versus ceftazidime/amikacin as empiric therapy in febrile neutropenic patients.
Leoni F; Ciolli S; Pascarella A; Fanci R; Caporale R; Rossi Ferrini P
Chemotherapy; 1993; 39(2):147-52. PubMed ID: 8458248
[TBL] [Abstract][Full Text] [Related]
5. Ceftriaxone versus ceftazidime plus aminoglycoside therapy for infections in patients with neutropenia after cytotoxic chemotherapy. Short communication.
Krcméry V; Danisovicová A; Drgona L; Spánik S; Fuchsberger P; Korec S; Svec J
Neoplasma; 1993; 40(2):103-5. PubMed ID: 8350953
[TBL] [Abstract][Full Text] [Related]
6. Treatment of febrile episodes in neutropenic leukemic patients with the antibiotic combinations piperacillin or ceftazidime plus amikacin: results of a randomized study.
Fenu S; Raccah R; Santilli S; Micozzi A; Girmena C; Martino P; Avvisati G
Chemioterapia; 1988 Oct; 7(5):323-6. PubMed ID: 3066517
[TBL] [Abstract][Full Text] [Related]
7. Ceftriaxone plus amikacin in neutropenic patients: a report on 100 cases.
Blanc C; Pollet JP; Bauters F
Chemotherapy; 1991; 37(5):382-8. PubMed ID: 1804600
[TBL] [Abstract][Full Text] [Related]
8. Meropenem monotherapy versus combination therapy with ceftazidime and amikacin for empirical treatment of febrile neutropenic patients.
Behre G; Link H; Maschmeyer G; Meyer P; Paaz U; Wilhelm M; Hiddemann W
Ann Hematol; 1998 Feb; 76(2):73-80. PubMed ID: 9540761
[TBL] [Abstract][Full Text] [Related]
9. Once daily ceftriaxone plus amikacin vs. three times daily ceftazidime plus amikacin for treatment of febrile neutropenic children with cancer. Writing Committee for the International Collaboration on Antimicrobial Treatment of Febrile Neutropenia in Children.
Charnas R; Lüthi AR; Ruch W
Pediatr Infect Dis J; 1997 Apr; 16(4):346-53. PubMed ID: 9109134
[TBL] [Abstract][Full Text] [Related]
10. Cefepime/amikacin versus ceftazidime/amikacin as empirical therapy for febrile episodes in neutropenic patients: a comparative study. The French Cefepime Study Group.
Cordonnier C; Herbrecht R; Pico JL; Gardembas M; Delmer A; Delain M; Moreau P; Ladeb S; Nalet V; Rollin C; Gres JJ
Clin Infect Dis; 1997 Jan; 24(1):41-51. PubMed ID: 8994754
[TBL] [Abstract][Full Text] [Related]
11. Multicenter, randomized trial of ciprofloxacin plus azlocillin versus ceftazidime plus amikacin for empiric treatment of febrile neutropenic patients.
Flaherty JP; Waitley D; Edlin B; George D; Arnow P; O'Keefe P; Weinstein RA
Am J Med; 1989 Nov; 87(5A):278S-282S. PubMed ID: 2686429
[TBL] [Abstract][Full Text] [Related]
12. Comparison of cefepime versus ceftriaxone-amikacin as empirical regimens for the treatment of febrile neutropenia in acute leukemia patients.
Borbolla JR; López-Hernández MA; González-Avante M; DeDiego J; Trueba E; Alvarado ML; Jiménez RM
Chemotherapy; 2001; 47(5):381-4. PubMed ID: 11561142
[TBL] [Abstract][Full Text] [Related]
13. A comparison of imipenem to ceftazidime with or without amikacin as empiric therapy in febrile neutropenic patients.
Rolston KV; Berkey P; Bodey GP; Anaissie EJ; Khardori NM; Joshi JH; Keating MJ; Holmes FA; Cabanillas FF; Elting L
Arch Intern Med; 1992 Feb; 152(2):283-91. PubMed ID: 1739355
[TBL] [Abstract][Full Text] [Related]
14. Ceftazidime plus amikacin plus teicoplanin or vancomycin in the empirical antibiotic therapy in febrile neutropenic cancer patients.
Nucci M; Biasoli I; Braggio S; Portugal R; Schaffel R; Maiolino A; Loureiro MM; Spector N; Pulcheri W
Oncol Rep; 1998; 5(5):1205-9. PubMed ID: 9683836
[TBL] [Abstract][Full Text] [Related]
15. [Imipenem/cilastatin versus ceftazidime-amikacin in the treatment of febrile neutropenic patients].
Pérez C; Sirham M; Labarca J; Grebe G; Lira P; Oliva J; Duhalde M; Ocqueteau M; Acuña G
Rev Med Chil; 1995 Mar; 123(3):312-20. PubMed ID: 8525170
[TBL] [Abstract][Full Text] [Related]
16. Management of fever in neutropenic patients with acute leukemia: current role of ceftazidime plus amikacin as empiric therapy.
Fanci R; Paci C; Martinez RL; Fabbri A; Pecile P; Leoni F; Longo G
J Chemother; 2000 Jun; 12(3):232-9. PubMed ID: 10877519
[TBL] [Abstract][Full Text] [Related]
17. Empirical antibiotic therapy in febrile neutropenic patients with single-daily dose amikacin plus ceftriaxone.
Suwangool P; Aswapokee N; Sathapatayavongs B; Leelasuphasri S; Siritanaratkul N; Chuncharunee S; Chayakul P
J Med Assoc Thai; 1993 Jun; 76(6):314-8. PubMed ID: 8083623
[TBL] [Abstract][Full Text] [Related]
18. Comparison of two antibiotic regimens (piperacillin plus amikacin versus ceftazidime plus amikacin) as empiric therapy for febrile neutropenic patients with cancer.
Feliu J; Artal A; González Barón M; Berrocal A; Chacón I; García de Paredes ML; Espinosa E; Ordóñez A; Zamora P; Montero JM
Antimicrob Agents Chemother; 1992 Dec; 36(12):2816-20. PubMed ID: 1482151
[TBL] [Abstract][Full Text] [Related]
19. Single-daily ceftriaxone plus amikacin versus thrice-daily ceftazidime plus amikacin as empirical treatment of febrile neutropenia in children with cancer.
Ariffin H; Arasu A; Mahfuzah M; Ariffin WA; Chan LL; Lin HP
J Paediatr Child Health; 2001 Feb; 37(1):38-43. PubMed ID: 11168867
[TBL] [Abstract][Full Text] [Related]
20. A randomised trial of empirical antibiotic therapy in febrile neutropenic patients with hematological disorders: ceftazidime versus azlocillin plus amikacin.
Gibson J; Date L; Joshua DE; Young GA; Wilson A; Benn R; Benson W; Iland H; Vincent PC; Kronenberg H
Aust N Z J Med; 1989 Oct; 19(5):417-25. PubMed ID: 2686610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
